Harnessing transposons for cancer gene discovery.

Articles citing this ↘

Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A (2013) 0.82

Clonal expansion analysis of transposon insertions by high-throughput sequencing identifies candidate cancer genes in a PiggyBac mutagenesis screen. PLoS One (2013) 0.82

Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies. Semin Cell Dev Biol (2014) 0.79

Cancer genetics: Evolution after tumour spread. Nature (2012) 0.78

Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats. Sci Rep (2016) 0.77

Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR. J Vis Exp (2013) 0.76

Exploiting the power of LINE-1 retrotransposon mutagenesis for identification of genes involved in embryonic stem cell differentiation. Stem Cell Rev (2014) 0.76

Applications of DNA integrating elements: Facing the bias bully. Mob Genet Elements (2015) 0.76

The utility of transposon mutagenesis for cancer studies in the era of genome editing. Genome Biol (2015) 0.76

In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies. Cell Mol Life Sci (2014) 0.76

Identifying transposon insertions and their effects from RNA-sequencing data. Nucleic Acids Res (2017) 0.76

Biological techniques: An embryonic view of tumour development. Nature (2013) 0.75

Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors. Cancers (Basel) (2016) 0.75

Case-oriented pathways analysis in pancreatic adenocarcinoma using data from a sleeping beauty transposon mutagenesis screen. BMC Med Genomics (2016) 0.75

Chromatin states shape insertion profiles of the piggyBac, Tol2 and Sleeping Beauty transposons and murine leukemia virus. Sci Rep (2017) 0.75

SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer. PLoS Genet (2017) 0.75

Integration site selection by retroviruses and transposable elements in eukaryotes. Nat Rev Genet (2017) 0.75

Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf(-/-) mouse model. Proc Natl Acad Sci U S A (2017) 0.75

Articles cited by this ↗

(truncated to the top 100)

The hallmarks of cancer. Cell (2000) 113.05

Mutations of the BRAF gene in human cancer. Nature (2002) 65.42

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56

Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res (2002) 40.03

Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64

'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06

Cytosine methylation and the ecology of intragenomic parasites. Trends Genet (1997) 13.66

Transcription start regions in the human genome are favored targets for MLV integration. Science (2003) 12.21

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06

Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell (1997) 8.68

Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A (1997) 8.35

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol (2004) 8.27

Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun (1997) 7.87

Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell (2005) 7.29

Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer (1988) 7.05

Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature (2005) 6.40

Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med (2002) 6.20

Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature (2005) 6.20

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (1991) 6.04

Comment on "The consensus coding sequences of human breast and colorectal cancers". Science (2007) 5.88

Inactivation of hCDC4 can cause chromosomal instability. Nature (2004) 5.71

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol (2010) 5.59

Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol (1983) 5.00

Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci U S A (2008) 4.98

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res (2000) 4.79

RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res (2004) 4.41

Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet (2000) 4.35

A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science (2009) 4.16

Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene (2006) 4.14

Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology (2008) 4.03

Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet (2009) 3.86

Cytosine methylation and mammalian development. Genes Dev (1999) 3.82

Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis (2007) 3.75

Preferential transposition of Drosophila P elements to nearby chromosomal sites. Genetics (1993) 3.67

Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol Ther (2003) 3.34

Resident aliens: the Tc1/mariner superfamily of transposable elements. Trends Genet (1999) 3.30

Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell (2008) 3.25

Comparing antibody and small-molecule therapies for cancer. Nat Rev Cancer (2006) 3.19

High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol (2005) 3.10

Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res (2007) 3.09

Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol Biol (1996) 3.02

Transposition and gene disruption in the male germline of the mouse. Genesis (2001) 2.98

Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci U S A (2001) 2.78

Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A (1998) 2.71

Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol (2002) 2.56

Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc Natl Acad Sci U S A (2001) 2.51

Splinkerettes--improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res (1995) 2.51

Genetics of hepatocellular carcinoma. Semin Cancer Biol (2000) 2.30

Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon. J Mol Biol (2002) 2.30

Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol (2000) 2.28

piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO J (2008) 2.27

Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc Natl Acad Sci U S A (2002) 2.24

Horizontal transmission, vertical inactivation, and stochastic loss of mariner-like transposable elements. Mol Biol Evol (1995) 2.13

Development of hyperactive sleeping beauty transposon vectors by mutational analysis. Mol Ther (2004) 2.13

Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci U S A (2002) 2.13

Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol Cell Biol (2003) 2.13

In vitro transposition of bacteriophage Mu: a biochemical approach to a novel replication reaction. Cell (1983) 2.08

High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer (2009) 2.06

Transposon mutagenesis of the mouse germline. Genetics (2003) 2.00

Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Comput Biol (2006) 1.92

Assay for movement of Lepidopteran transposon IFP2 in insect cells using a baculovirus genome as a target DNA. Virology (1995) 1.90

A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res (2009) 1.86

Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet (2006) 1.84

Target-site preferences of Sleeping Beauty transposons. J Mol Biol (2004) 1.83

Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med (1992) 1.74

Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature (2009) 1.72

Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons. Genesis (2009) 1.68

Comparative analysis of transposable element vector systems in human cells. Mol Ther (2010) 1.66

Healing the wounds inflicted by sleeping beauty transposition by double-strand break repair in mammalian somatic cells. Mol Cell (2004) 1.64

Comment on "The consensus coding sequences of human breast and colorectal cancers". Science (2007) 1.62

Identification of functional domains and evolution of Tc1-like transposable elements. Proc Natl Acad Sci U S A (1996) 1.56

Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene (2003) 1.52

The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res (2003) 1.45

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Res (2007) 1.43

Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation. Mol Cell Biol (2004) 1.41

Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol (2003) 1.37

Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat (2004) 1.36

Comment on "The consensus coding sequences of human breast and colorectal cancers". Science (2007) 1.35

Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res (2009) 1.34

Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biol Ther (2006) 1.32

Sleeping beauty transposase has an affinity for heterochromatin conformation. Mol Cell Biol (2006) 1.23

Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res (2009) 1.22

MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course. Clin Cancer Res (2004) 1.21

Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes. J Biol Chem (1990) 1.21

Mutation rate of MAP2K4/MKK4 in breast carcinoma. Hum Mutat (2002) 1.21

Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm. Exp Cell Res (2003) 1.19

Sleeping Beauty transposase modulates cell-cycle progression through interaction with Miz-1. Proc Natl Acad Sci U S A (2006) 1.19

Postintegrative gene silencing within the Sleeping Beauty transposition system. Mol Cell Biol (2007) 1.15

In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells. Int J Oncol (2007) 1.11

Retroviral insertion sites and cancer: fountain of all knowledge? Cancer Cell (2002) 1.09

Pooled library tissue tags for EST-based gene discovery. Bioinformatics (2002) 1.01

DNA methylation of Sleeping Beauty with transposition into the mouse genome. Genes Cells (2005) 1.01

Deciphering the genetic landscape of cancer--from genes to pathways. Trends Genet (2009) 0.98

Sleeping Beauty transposition in the mouse genome is associated with changes in DNA methylation at the site of insertion. Genomics (2006) 0.96

Tagged mutagenesis by efficient Minos-based germ line transposition. Mol Cell Biol (2010) 0.93

Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. Int J Cancer (2005) 0.89

A minor tyrosine phosphorylation site located within the CAIN domain plays a critical role in regulating tissue-specific transformation by erbB kinase. J Virol (1995) 0.88

Efficient transposition of Tol2 in the mouse germline. Genetics (2009) 0.87

Articles by these authors ⇆

(truncated to the top 100)

A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res (2003) 12.94

Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res (2005) 11.23

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med (2006) 9.68

Onset and progression in inherited ALS determined by motor neurons and microglia. Science (2006) 9.42

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31

Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature (2005) 6.20

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet (2003) 5.92

Identification of Vangl2 and Scrb1 as planar polarity genes in mammals. Nature (2003) 4.56

RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res (2004) 4.41

A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science (2009) 4.16

New genes involved in cancer identified by retroviral tagging. Nat Genet (2002) 4.14

Identification of an organelle receptor for myosin-Va. Nat Cell Biol (2002) 4.06

Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci U S A (2003) 3.93

Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet (2004) 3.78

The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol (2008) 3.55

Bcl11a is essential for normal lymphoid development. Nat Immunol (2003) 3.48

A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol (2009) 3.44

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.33

Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood (2005) 2.93

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci (2006) 2.85

Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet (2003) 2.78

Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science (2010) 2.77

Asymmetric localization of Vangl2 and Fz3 indicate novel mechanisms for planar cell polarity in mammals. J Neurosci (2006) 2.73

Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat Methods (2005) 2.70

Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet (2003) 2.64

Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J (2004) 2.55

Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat Genet (2002) 2.46

Myosin-1a is critical for normal brush border structure and composition. Mol Biol Cell (2005) 2.44

Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med (2005) 2.43

Efficient Cre-loxP-induced mitotic recombination in mouse embryonic stem cells. Nat Genet (2001) 2.14

Gene therapy insertional mutagenesis insights. Science (2004) 1.99

Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis (2002) 1.96

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One (2011) 1.93

Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood (2005) 1.91

Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice. EMBO J (2006) 1.88

A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res (2009) 1.86

Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A (2012) 1.82

Cell of origin strongly influences genetic selection in a mouse model of T-ALL. Blood (2011) 1.78

Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature (2009) 1.72

Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc Natl Acad Sci U S A (2002) 1.70

Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis (2005) 1.69

Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation. Hum Mol Genet (2005) 1.63

Zfp423 is required for normal cerebellar development. Mol Cell Biol (2006) 1.62

BCL11B is required for positive selection and survival of double-positive thymocytes. J Exp Med (2007) 1.59

Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. Circ Res (2008) 1.54

Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat Genet (2003) 1.54

Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med (2012) 1.51

Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol (2003) 1.47

A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci (2004) 1.45

Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood (2012) 1.45

Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood (2005) 1.34

Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res (2009) 1.34

Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology (2010) 1.33

Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J Exp Med (2003) 1.29

Highly restricted expression of Cre recombinase in cerebellar Purkinje cells. Genesis (2004) 1.26

Mouse coat color mutations: from fancy mice to functional genomics. Dev Dyn (2006) 1.22

Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev Cell (2010) 1.21

Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10. Blood (2012) 1.21

Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet (2009) 1.19

Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics (2002) 1.18

Sleeping beauty: a novel cancer gene discovery tool. Hum Mol Genet (2006) 1.17

Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein. Blood (2002) 1.17

A comprehensive SNP-based genetic analysis of inbred mouse strains. Mamm Genome (2005) 1.16

The tetraspanin protein peripherin-2 forms a complex with melanoregulin, a putative membrane fusion regulator. Biochemistry (2007) 1.15

APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging (2004) 1.15

Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis. PLoS Genet (2013) 1.15

The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis (2004) 1.14

Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas. Oncogene (2004) 1.13

Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. J Exp Med (2011) 1.13

Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model. Hum Mol Genet (2010) 1.12

BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J Neurosci (2008) 1.12

Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Hum Mol Genet (2004) 1.11

Visualization and identification of IL-7 producing cells in reporter mice. PLoS One (2009) 1.11

Identification of beta-carotene 15, 15'-monooxygenase as a peroxisome proliferator-activated receptor target gene. FASEB J (2003) 1.10

Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood (2012) 1.09

Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood (2004) 1.09

Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development. Development (2012) 1.07

Itch genetically interacts with Notch1 in a mouse autoimmune disease model. Hum Mol Genet (2006) 1.06

The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the nuclear export receptor NXF1. J Biol Chem (2009) 1.06

Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b. J Exp Med (2010) 1.05

Comparative genetics and evolution of annexin A13 as the founder gene of vertebrate annexins. Mol Biol Evol (2002) 1.03

Interallelic complementation at the mouse Mitf locus. Genetics (2003) 1.02

The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway. J Biol Chem (2002) 1.02

The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background. Blood (2002) 1.02

Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun (2003) 1.02

Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiol Dis (2005) 1.01

Differential expression of the seven-pass transmembrane cadherin genes Celsr1-3 and distribution of the Celsr2 protein during mouse development. Dev Dyn (2002) 1.00

Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes. Proc Natl Acad Sci U S A (2011) 1.00

BHLHB4 is a bHLH transcriptional regulator in pancreas and brain that marks the dimesencephalic boundary. Genomics (2002) 1.00

dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice. Proc Natl Acad Sci U S A (2004) 1.00

A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis. EMBO J (2012) 0.99

Melanocyte stem cell maintenance and hair graying. Cell (2005) 0.99

The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue. Genetics (2009) 0.99

Deciphering the genetic landscape of cancer--from genes to pathways. Trends Genet (2009) 0.98

Genetic control of myeloproliferation in BXH-2 mice. Blood (2003) 0.98

Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients. J Natl Cancer Inst (2012) 0.98

Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells. Proc Natl Acad Sci U S A (2012) 0.98

Melanoregulin regulates a shedding mechanism that drives melanosome transfer from melanocytes to keratinocytes. Proc Natl Acad Sci U S A (2012) 0.97

Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors. Proc Natl Acad Sci U S A (2012) 0.96

Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroups. Proc Natl Acad Sci U S A (2013) 0.95

PubWeight™: 2.44^‹?› | Rank: Top 2%

🔗 View Article (PMID 20844553)

Authors

Author Affiliations

Articles citing this ↘

Articles cited by this ↗

(truncated to the top 100)

Articles by these authors ⇆

(truncated to the top 100)

Harnessing transposons for cancer gene discovery.

PubWeight™: 2.44‹?› | Rank: Top 2%

🔗 View Article (PMID 20844553)

Authors

Author Affiliations

Articles citing this ↘

Articles cited by this ↗

(truncated to the top 100)

Articles by these authors ⇆

(truncated to the top 100)

PubWeight™: 2.44^‹?› | Rank: Top 2%